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Abstract
Background: Electronic personal health records (PHRs) can support patient self-management of chronic conditions. Managing
human immunodeficiency virus (HIV) viral load, through taking antiretroviral therapy (ART) is crucial to long term survival of
persons with HIV. Many persons with HIV have difficulty adhering to their ART over long periods of time. PHRs contribute to
chronic disease self-care and may help persons with HIV remain adherent to ART. Proportionally veterans with HIV are among
the most active users of the US Department of Veterans Affairs (VA) PHR, called My HealtheVet. Little is known about whether
the use of the PHR is associated with improved HIV outcomes in this population.
Objective: The objective of this study was to investigate whether there are associations between the use of PHR tools (electronic
prescription refill and secure messaging [SM] with providers) and HIV viral load in US veterans.
Methods: We conducted a retrospective cohort study using data from the VA’s electronic health record (EHR) and the PHR.
We identified veterans in VA care from 2009-2012 who had HIV and who used the PHR. We examined which ones had achieved
the positive outcome of suppressed HIV viral load, and whether achievement of this outcome was associated with electronic
prescription refill or SM. From 18,913 veterans with HIV, there were 3374 who both had a detectable viral load in 2009 and who
had had a follow-up viral load test in 2012. To assess relationships between electronic prescription refill and viral control, and
SM and viral control, we fit a series of multivariable generalized estimating equation models, accounting for clustering in VA
facilities. We adjusted for patient demographic and clinical characteristics associated with portal use. In the initial models, the
predictor variables were included in dichotomous format. Subsequently, to evaluate a potential dose-effect, the predictor variables
were included as ordinal variables.
Results: Among our sample of 3374 veterans with HIV who received VA care from 2009-2012, those who had transitioned
from detectable HIV viral load in 2009 to undetectable viral load in 2012 tended to be older (P=.004), more likely to be white
(P<.001), and less likely to have a substance use disorder, problem alcohol use, or psychosis (P=.006, P=.03, P=.004, respectively).
There was a statistically significant positive association between use of electronic prescription refill and change in HIV viral load
status from 2009-2012, from detectable to undetectable (OR 1.36, CI 1.11-1.66). There was a similar association between SM
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use and viral load status, but without achieving statistical significance (OR 1.28, CI 0.89-1.85). Analyses did not demonstrate a
dose-response of prescription refill or SM use for change in viral load.
Conclusions: PHR use, specifically use of electronic prescription refill, was associated with greater control of HIV. Additional
studies are needed to understand the mechanisms by which this may be occurring.
(J Med Internet Res 2017;19(2):e34)   doi:10.2196/jmir.6932
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Introduction
Electronic health records (EHRs) are increasingly being adopted
by hospitals, health plans, and other health care providers to
improve the efficiency and effectiveness of health care delivery,
meet provisions of the Affordable Care Act, and to qualify for
Meaningful Use financial incentives [1-3]. Many of these EHRs
include personal health records (PHRs, also known as “patient
portals”), which enable patients to view parts of their medical
record such as laboratory results, past and future appointments,
and upcoming preventive care. Patients can also use PHRs to
manage their own care and communicate with their health care
providers including sending secure electronic messages to their
clinical providers. A common PHR feature, electronic refill of
prescriptions (hereafter called “Rx refill”), for example, may
contribute to better medication adherence by ensuring that
patients consistently have their medications on hand [4].
Similarly, there is evidence that secure messaging (SM) may
contribute to increased likelihood of achieving chronic illness
control, such as diabetes and hypertension, because of improved
patient-provider communication [5-7]. These PHR
self-management tools may be especially beneficial for persons
with human immunodeficiency virus (HIV) who must carefully
adhere to their combination antiretroviral therapy (ART), but
also often have other chronic conditions that they must manage
simultaneously [8].
Controlling the amount of HIV virus in the bloodstream is
crucial to persons with HIV, and combination ART is highly
effective at reducing HIV viral load when taken as prescribed.
But the management of HIV is complex. Patients must carefully
adhere to their ART regimen both to control viremia and to
reduce the likelihood of drug resistance. Lab work is needed
regularly to monitor HIV virus levels and the status of the
immune system through CD4 cell counts [9]. Additionally,
many persons with HIV have comorbid chronic mental and
physical health conditions that may lead to drug-drug
interactions or disease-drug interactions with ART [8]. This
suggests that patients with HIV would benefit from frequent
provider-patient communication and the ability to easily manage
and order their medications [10-12]. PHR self-management
tools, in particular Web-based prescription refills and SM, may
facilitate patients’ adherence to ART and thus contribute to
subsequent undetectable viral load [13,14]. However, to our
knowledge no studies have examined whether the use of specific
PHR features of prescription refill and SM are associated with
improved clinical outcomes for persons with HIV.
This study examines use of the My HealtheVet PHR Rx refill
and SM features by persons with HIV in a large integrated health
care system. We sought to examine whether use of these tools
was associated with undetectable viral load. To this end, we
identified a cohort of HIV-infected veterans receiving US
Department of Veterans Affairs (VA) health care and examined
their patterns of My HealtheVet PHR use along with their
laboratory results for HIV viral load status in 2 time periods.
Methods
Study Design
We conducted a retrospective cohort study, identifying veterans
with HIV who used the My HealtheVet PHR and followed them
to assess outcomes of suppression of viral load. The study was
approved by the Bedford Massachusetts VA Medical Center
Institutional Review Board.
Setting
We used data from the VA system of medical records available
through the VA Corporate Data Warehouse (CDW). Variables
included patient demographics and International Classification
of Disease, 9th revision, clinical modification (ICD-9-CM)
diagnosis codes associated with all VA inpatient and outpatient
encounters from October 1, 2007, to March 31, 2012. These
data were linked at the patient level with My HealtheVet
registration, SM, and Rx refill data from April 2012.
Sample
The study population included all American veterans aged 18
years and older who had obtained care from the VA health care
system between April 1, 2010, and March 31, 2012
(N=6,012,875). Obtaining care in the VA was defined as having
at least two outpatient visits or 1 inpatient hospitalization for
any cause during this period. The cohort of HIV-infected patients
was identified by examining VA’s decision support system
laboratory results contained in CDW. Inclusion criteria for the
cohort were: (1) a veteran determined to be HIV positive based
on 2 or more instances of ICD-9-CM codes for HIV in the CDW,
(2) had a detectable viral load in 2009, and (3) had viral load
test results (detectable or undetectable) in 2012. For these
analyses, an undetectable viral load was considered less than
200 copies of the HIV virus per milliliter (mL) of blood
(<200/mL); conversely, 200 copies or more of the HIV virus
per mL of blood (>=200/mL) indicated a detectable viral load.
We identified 18,913 veterans who were HIV-positive and had
a viral load test result in 2009 (See Figure 1). Of these, 4202
had a detectable viral load. Among these 4202 there were 3374
veterans who had a viral load test result in 2012. These 3374
veterans were the subject of this study. However, in the
multivariable analyses, the total sample was 3289 due to missing
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values for 85 patients. For patients with multiple viral load tests
in a given year, the most recent result in that calendar year
(closest to December 31) was used to categorize the patient’s
viral load status.
Figure 1. Creation of analytical database.
VA’s Personal Health Record, My HealtheVet
VA launched the My HealtheVet PHR in 2003 and enrollment
has grown to approximately 3.5 million current registered users
as of January 2016 [15]. The PHR provides evidence-based
health information, health logs (eg, to track diet, exercise,
weight), access to providers’ notes, reminders for preventive
health services (eg, immunization, cancer screening),
prescription drug refills, and secure email messaging [16]. Since
2005, over 70 million prescription refills have been requested
on the Web, and 1.7 million veterans have signed up for the SM
service. Interestingly, veterans with HIV register for the My
HealtheVet PHR at higher rates than veterans with other chronic
illnesses. While 18.64% of all veterans receiving treatment from
VA were registered to use the PHR in 2012, 26.48% of veterans
with HIV were registered at the time [15].
Data Collection
Independent Variables
Use of My HealtheVet Rx refill and SM features were the
independent variables of interest. We examined whether each
of these tools was used by each veteran in our sample in the
3-year follow-up period from 2010-2012, and whether use of
the tool was associated with undetectable viral load. These 2
variables were dichotomous with 1 indicating use of Rx refill
at least one time in the 2010-12 period, and 0 indicating no use
of Rx refill during that time period. The SM variable was created
in the same way, with 1 indicating at least one use in 2010-12
and 0 indicating no use during that time period. In separate
analyses, we also explored whether there may be a dose-response
such that sustained use of the tool (Rx refill or SM) was
associated with an increased likelihood of having an
undetectable viral load. For those analyses, each of the variables
(Rx refill and SM) was coded as an ordinal variable with 0
indicating no use in 2010-12, 1 indicating use in only 1 of the
3 years, and 2 indicating use in 2 or more of the 3 years.
Dependent Variable
The outcome of interest was viral load status in 2012. It was
coded 1 for viral load < 200 mL (undetectable) and 0 for viral
load >=200 mL (detectable).
Covariates
Following Shimada et al who examined electronic prescription
refill and SM among 6 million veterans using VA health
services, we included in our multivariable analyses the following
demographic characteristics: age, gender, race or ethnicity,
urban or rural residence based on home postal code, and
economic need defined as eligibility for free care based on an
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annual VA means testing [15]. We grouped participants by age
(<45 years or 45-54 years or 55-64 years or 65+ years), marital
status (married vs never married or divorced or separated or
widowed), and race or ethnicity (African American vs White
or Asian or Native Hawaiian or American Indian or other).
Chronic conditions and disease burden were measured using
ICD-9-CM medical and mental health diagnoses that appeared
at least once for an inpatient stay or at least twice for outpatient
visits. The diagnostic grouping to identify chronic conditions
had been previously validated in a large VA longitudinal study
of veterans with HIV [17]. Comorbidities may have influenced
both disease self-management behaviors and interest in using
the PHR. We included comorbidities in our models in 2 ways.
First, problem alcohol use, other substance use, depression, and
psychoses were each included as independent variables,
following their identification using ICD-9-CM codes, as
described earlier. These 4 conditions were singled out because
of their relatively high prevalence among HIV-infected
populations [18,19] and their known negative association with
medication adherence [20-22]. In addition, as an overall measure
of chronic disease burden, we used the Elixhauser score [23-25].
This is a summary measure of disease burden that combines 31
common comorbidities. Because all patients in our sample were
HIV positive, we adjusted the Elixhauser measure by removing
HIV disease. In addition, we removed problem alcohol use,
substance use, depression, and psychoses from the Elixhauser
measure because they had already been included as independent
variables as described previously.
Analyses
We began by examining bivariate relationships between HIV
viral control and the independent variables using cross-tabulation
and chi-square tests. To assess relationships between Rx refill
and viral control, and SM and viral control, with the sample of
3289 patients, we fit a series of multivariable generalized
estimating equation models, accounting for clustering in VA
facilities. To understand how patient characteristics might bias
the primary association of Rx refill (or SM) and viral control,
our models controlled for socio-demographics (age, gender,
race or ethnicity, economic need, marital status, rural or urban
status) and health status (ie, Elixhauser comorbidity burden, as
well as separate indicators of alcohol use, other substance use,
depression, and psychoses). We ran models for Rx refill and
SM separately. In initial models the predictor variables were
included in dichotomous format. Subsequently, to evaluate a
potential dose-effect, the predictor variables were included as
ordinal, as described previously. This produced 4 different
models. We considered statistical significance to be P<.05. To
assess potential multicollinearity, we estimated variance inflation
factor (VIF) for each independent variable in each of our
multivariable models. No variables had VIF greater than 10 (the
largest VIF was 1.61) suggesting there was little or no
multicollinearity. This also suggests sampling bias was not a
substantial issue. To assess whether being registered to use the
PHR or not would affect our findings, we conducted sensitivity
analyses in which we restricted the sample to the 1130 registered
patients. When we ran the same 4 regression models, our results
did not differ substantially from the original 4 models. Thus in
the results section discussed later on, we focus on the analyses
using the larger sample of 3289 patients.
Results
Patient Characteristics and PHR Use
Sociodemographic, health, and PHR use data are shown in Table
1, by viral load detectable status in 2012. Of the 3374 who had
detectable viral loads in 2009, 66.60% had undetectable viral
loads in 2012. Nearly three-quarters (71.61%) of the sample
were in the 45-64 year age range, and 96.21% were male
(consistent with the demographics of the US veteran population).
The majority of the sample was African American (61.53%).
Close to half (46.06%) were considered having high economic
need, based on eligibility for free VA health care services due
to low income, and 11.47% were married. Most of the sample
(88.97%) lived in urban areas. There were considerable mental
health and substance use disorder morbidity, including 60.04%
with a diagnosis of depression, 41.44% with a substance use
disorder, 32.99% with problem alcohol use, and 6.32% with
psychoses. Excluding the aforementioned 4 diagnoses and HIV,
subjects had a mean of 2.7 chronic conditions (as assessed with
the Elixhauser score). One-third (33.49%) had registered for
the PHR as of 2012. In addition 17.81% of the sample had used
the PHR’s electronic prescription refill at least once in the
2010-2012 period, and 5.93% had sent at least one secure
message to a VA provider during that period.
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Table 1. Participant characteristics, overall and by human immunodeficiency virus (HIV) viral control in 2012.
P valueViral controlOverall, n (%)Vari-
able
Viral load detectable, n (%)Viral load undetectable, n (%)
1127 (33.40)2247 (66.60)3374 (100)
.003   Age in years
223 (19.79)414 (18.42)637 (18.88)<45
414 (36.73)776 (34.53)1190 (35.27)45-54
412 (36.56)814 (36.23)1226 (36.34)55-64
78 (6.92)243 (10.81)321 (9.51)65+
.05   Gender
53 (4.70)75 (3.34)128 (3.79)Female
1074 (95.30)2172 (96.66)3246 (96.21)Male
<.001   Race
304 (26.97)826 (36.76)1130 (33.49)White
767 (68.06)1309 (58.26)2076 (61.53)Black
13 (1.15)15 (0.67)28 (0.83)Hispanic
5 (0.44)24 (1.07)29 (0.86)Native Hawaiian
4 (0.35)10 (0.45)14 (0.41)American Indian
3 (0.27)8 (0.36)11 (0.33)Asian
31 (2.75)55 (2.45)86 (2.55)Unknown
.22   Economic need (means test)
536 (47.56)1018 (45.30)1554 (46.06)Eligible for free care
591 (52.44)1229 (54.70)1820 (53.94)Not eligible
.001   Marital status
128 (11.36)259 (11.53)387 (11.47)Married
527 (46.76)1040 (46.28)1567 (46.44)Never married
337 (29.90)700 (31.15)1037 (30.74)Divorced
74 (6.57)154 (6.85)228 (6.76)Separated
37 (3.28)83 (3.69)120 (3.56)Widowed
24 (2.13)11 (0.49)35 (1.04)Others
.18   Urban or rural location
31 (2.75)51 (2.27)82 (2.43)Missing
1012 (89.80)1990 (88.56)3002 (88.97)Urban
84 (7.45)206 (9.17)290 (8.60)Rural
   Comorbidities
.07699 (62.19)1325 (58.97)2024 (60.04)Depression (% yes)
.006503 (44.75)894 (39.79)1397 (41.44)Substance use (% yes)
.03399 (35.50)713 (31.73)1112 (32.99)Problem alcohol use (% yes)
.00490 (8.01)123 (5.47)213 (6.32)Psychoses (% yes)
.572.72 (2.31)2.67 (2.38)2.69 (2.35)Elixhauser comorbidity score, mean (STD)
   My HealtheVet PHR Use
.01345 (30.61)785 (34.94)1130 (33.49)Registered to use My HealtheVet as of 2012
<.001166 (14.73)435 (19.36))601 (17.81)Use Rx refill (2010-2012)
.0353 (4.70)147 (6.54)200 (5.93)Use secure messaging (2010-2012)
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There were differences between veterans with undetectable
versus detectable viral load. Veterans with undetectable viral
load were older (10.81% vs 6.92%, 65+ years), more likely to
be male (96.66% vs 95.30%), white (36.76% vs 26.97%), and
divorced (31.15% vs 29.90%). They were less likely than
veterans with detectable viral load to have symptoms of
depression (58.97% vs 62.19%), substance use disorder (39.79%
vs 44.75%), problem alcohol use (31.73% vs 35.50%), or
psychoses (5.47% vs 8.01%). Those with undetectable viral
load were also more likely to be registered for My HealtheVet
(34.94% vs 30.61%), to have used Rx refill (19.36% vs 14.73%),
and to have used SM (6.54% vs 4.70%).
Multivariable Models
In our multivariable model examining use of Rx refill, there
was a positive association between use of Rx refill and viral
load control (Table 2). Veterans using Rx refill had 1.36 the
odds (95% CI 1.11-1.66) of having an undetectable viral load
compared with veterans who did not use Rx refill, after adjusting
for sociodemographic and health variables. In addition, older
age (Odds ratio, OR 1.01, 95% CI 1.00-1.02) and being white
(OR 1.49, 95% CI 1.21-1.83) were independently and positively
associated with undetectable viral load, whereas a diagnosis of
psychosis (OR 0.66, 95% CI 0.46-0.95) was associated with
reduced likelihood of undetectable viral load.
Table 2. Multivariable analysis of the odds of undetectable viral load in 2012 in relation to Rx refill use (n=3289).
P value95% CIOdds ratioEstimateVariable
.0031.11-1.661.360.3085Use Rx refill 2010-2012 (dichotomous)
.0041.00-1.021.010.0132Age
.220.86-1.941.290.2555Male
<.0011.21-1.831.490.399White race
.190.78-1.050.90-0.101Economic need (means test)
.610.78-1.160.95-0.053Married
.610.96-1.030.99-0.009Elixhauser score
.930.84-1.170.99-0.007Problem alcohol use
.600.76-1.180.94-0.059Substance use
.440.79-1.110.94-0.067Depression
.030.46-0.950.66-0.417Psychoses
.330.86-1.571.160.1506Rural
There were similar associations when viral load was modeled
with SM as the predictor variable. However, SM did not achieve
a statistically significant association with viral load status (Table
3). Veteran using SM had 1.28 the odds (95% CI 0.89-1.85) of
having undetectable viral load compared with veterans who did
not use SM, after adjusting for sociodemographic and health
variables. Similar to the Rx refill model, older age (OR 1.01,
95% CI 1.00-1.02) and being white (OR 1.53, 95% CI 1.25-1.86)
were independently and positively associated with undetectable
viral load. Conversely, a diagnosis of psychosis (OR 0.66, 95%
CI 0.46-0.95) was associated with reduced likelihood of having
an undetectable viral load.
Table 3. Multivariable analysis of the odds of undetectable human immunodeficiency virus (HIV) viral load in 2012 in relation to secure messaging
(SM) use (n=3289).
P value95% CIOdds ratioEstimateVariable
.190.89-1.851.2790.2462Use secure messaging
.011.00-1.021.0120.0114Age
.190.87-1.991.3160.2748Male
<.0011.25-1.861.5270.4231White race
.150.78-1.040.898-0.107Economic need (means test)
.530.77-1.150.939-0.063Married
.640.96-1.030.992-0.008Elixhauser score
.830.84-1.160.983-0.017Problem alcohol use
.510.75-1.160.929-0.073Substance use
.510.80-1.120.944-0.057Depression
.030.46-0.950.659-0.416Psychoses
.330.86-1.581.1630.1509Rural
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There was no evidence of a dose effect for either Rx refill or
SM when treated as ordinal variables (Tables 4 and 5). The
overall association of Rx refill with undetectable viral load,
however, was still evident. Compared with veterans with 0 uses
of Rx refill, those with Rx refill use in 1 year had 1.38 the odds
of undetectable viral load (95% CI 1.02-1.87) and those with
Rx refill use in 2+ years had nearly the same odds ratio (OR
1.35, 95% CI 1.07-1.71) (Table 4).
Table 4. Multivariable analysis of the odds of undetectable human immunodeficiency virus (HIV) viral load in 2012 in relation to Rx refill use (Rx
refill included as ordinal variable), for assessment of dose effect (n=3289).
P value95% CIOdds ratioEstimateVariable
----Use Rx refill 0 years (ref)
.041.02-1.871.3760.3194Use Rx refill 1 year
.011.07-1.711.3520.3016Use Rx refill 2-3 years
.0041.00-1.021.0130.0132Age
.220.86-1.941.2910.2556Male
<.0011.21-1.831.4910.3995White race
.190.78-1.050.904-0.101Economic need (means test)
.610.78-1.160.949-0.052Married
.610.96-1.030.991-0.009Elixhauser score
.930.84-1.170.993-0.007Problem alcohol use
.600.76-1.170.943-0.059Substance use
.440.79-1.110.935-0.067Depression
.030.46-0.950.659-0.417Psychoses
.330.86-1.571.1620.1501Rural
The findings for SM also indicated no evidence of dose effect.
The odds ratio for SM use in 1 year was 1.37 (95% CI 0.88-2.13)
and for SM use in 2+ years was 1.02 (95% CI 0.51-2.01) though
neither was statistically significant (Table 5).
Table 5. Multivariable analysis of the odds of undetectable human immunodeficiency virus (HIV) viral load in 2012 in relation to secure messaging
(SM) use (as ordinal variable), for assessment of dose effect (n=3289).
P value95% CIOdds ratioEstimateVariable
----Secure messaging 0 years (reference)
.160.88-2.131.3710.3157Secure messaging 1 year
.970.51-2.011.0150.0149Secure messaging 2-3 years
.011.00-1.021.0120.0114Age
.190.87-1.991.3180.2759Male
<.0011.25-1.871.530.4252White race
.160.77-1.040.9-0.106Economic need (means test)
.530.77-1.140.938-0.064Married
.620.96-1.030.992-0.008Elixhauser score
.840.84-1.160.983-0.017Problem alcohol use
.510.75-1.160.929-0.073Substance use
.510.80-1.120.945-0.056Depression
.030.45-0.950.657-0.421Psychoses
.340.86-1.581.1620.1501Rural
Our sensitivity analyses, in which the regression models were
reestimated using the restricted sample of the 1130 registered
patients, did not yield any substantively different results than
those presented in Tables 2-5- (data not shown).
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Discussion
Principal Findings
We found that among veterans with HIV, there was a positive
association between My HealtheVet PHR use and undetectable
viral load. Specifically, veterans who had detectable viral loads
in 2009, and who used the Rx refill function between 2010 and
2012, had 1.36 times the likelihood of undetectable viral load
in 2012 compared with veterans who did not use Rx refill. There
was no evidence of dose effect of either of Rx refill or SM on
the likelihood of undetectable viral load. No observational study
can prove causality, but we had features that support a causal
argument—we identified a longitudinal relationship, but not a
clear dose-response. Thus it is possible that PHR use is a marker
for some unmeasured covariates, such as engagement with the
health care system.
Limitations
Due to the study limitations, we cannot rule out that there may
be other explanations for our main finding of an association
between use of Rx refill and undetectable viral load. The most
salient limitation is that as an observational study there is
potential for confounding by indication, in that patients who
are already activated to improve their health may also be more
likely to try new tools, such as PHRs. It is possible that more
empowered and self-efficacious patients decide to use a PHR,
whereas patients who are less motivated and more challenged
with self-management tasks do not. Self-efficacy and
empowerment may be driving forces behind achievement of
undetectable viral load, and not actually PHR use alone.
However, by limiting our analytic sample to the HIV positive
veterans who had uncontrolled viral load in 2009, we sought to
minimize variation in self-efficacy and empowerment. Another
important variable, which was not available in our dataset and
thus not included in our models, is stigma. Data indicate that
Web-based tools are seen as particularly valuable, and used
more often, among persons with stigmatized health conditions
than among persons with nonstigmatized conditions [26]. Degree
of perceived stigma may have been affecting the results found
in our study.
Additionally, the linkage between Web-based prescription refill
and undetectable viral load is presumably mediated by proper
medication taking and medication adherence. Our data did not
permit us to evaluate medication adherence, or whether the PHR
prescription refills were specifically for ART as compared with
medications for other comorbid conditions (eg, for diabetes,
hypertension). Additional studies are needed that address these
limitations, for example by randomizing patients to PHR use,
and by assessing ART adherence to see whether the trajectory
from PHR use to undetectable viral load occurs though the
expected taking of ART. Our sample was all veterans and mostly
male, therefore our results may not be generalizable to
nonveterans and to women. Another way that generalizability
may be limited is that the VA is unlike many smaller health care
systems in that it has succeeded in registering a large number
of its patients for PHR use, approximately 3.5 million users as
of 2016 [15]. This number is likely only exceeded in the United
States by the number of users in the Kaiser Permanente health
care system [27]. Additionally the VA’s PHR has more features
than many other PHR systems (including the recent addition of
OpenNotes—that is, patient access to clinician notes [28]),
which may be one of the reasons for the relatively high patient
enrollment rates. While these unique features of the VA’s PHR
reduce generalizability, alternatively the sheer number of users
makes the VA an ideal environment for examining the impact
of PHRs on health care delivery, processes, and outcomes, even
for conditions with relatively low prevalence such as HIV.
Comparison With Prior Work
Overall evidence on the effect of PHR use on care processes
and outcomes for a variety of health conditions show mixed
results [29]. While Zhou et al found an association between
patient SM use and improved intermediate outcomes for
hypertension, cholesterol, and diabetes [5], a clinical trial
conducted by Wagner et al randomly assigning subjects to PHR
access or no access found no effects of PHR access on
hypertension control, though subanalyses of frequent PHR users
showed they achieved reductions in diastolic blood pressure,
compared with the infrequent PHR users [30]. In a retrospective
study of patients with diabetes at the Cleveland Clinic, Tenforde
et al found in adjusted multivariable analyses that in a PHR user
group compared with nonuser group there was more hemoglobin
A1c (HbA1c) testing and lower HbA1c values (7.0% in the
PHR group vs 7.3% in the non-PHR group; P<.01) [31]. A study
of veterans who were using the My HealtheVet PHR found that
use of Rx refill and SM were both associated with improved
low density lipoprotein cholesterol levels. It also found sustained
use (use each year over 3 or more years) of SM was associated
with improved HbA1c levels among veterans with diabetes,
whereas sustained use of Rx refill was associated with improved
blood pressure control among veterans with hypertension [32].
In yet another diabetes study conducted with 54 patients at
Vanderbilt University Medical Center, Wade-Vuturo et al found
that use of the PHR’s SM feature (more vs fewer messages sent)
was moderately associated with lower HbA1c values in
Spearman correlation analyses, (ρ=-.29, P=.04) [33].
In HIV, similarly, the evidence is mixed, with several studies
suggesting that PHR use may assist with care processes and
outcomes, but at least one study finding no association. A 6-site
study by Shade et al [34] used a serial cross-sectional design in
which each site selected a different health IT intervention to
improve HIV care. One site introduced a continuity of care
summary accessible to patients via a portal. At that site, based
on data from 500 patients, there was an increased odds of
undetectable viral load from baseline (prior to patient continuity
of care summary) to follow up (OR 1.36, 95% CI 1.09-1.71)
[34,35]. Patients were selected to be representative of the clinic
population without regard for whether they used the continuity
of care summary. A study by Crouch et al [36] found that PHR
use was associated with improved HIV control. The team
identified 80 HIV+ veterans using a nonprobability quota
sample, selected to be split evenly between using and not using
VA’s My HealtheVet PHR. There was a statistically significant
association between My HealtheVet PHR use and undetectable
viral load, with 95% having undetectable viral load in the PHR
group compared with 70% in the non-PHR group (P=.046) [36].
This study did not examine which components of the PHR
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patients used. McInnes et al reported that in a cross-sectional
sample of 1871 veterans, multivariable analyses found that
self-reported PHR use was associated with pharmacy refill ART
adherence [4]. The findings from logistic regression analyses
by Gordon et al, in contrast to the other studies, found in
comparing 39 PHR users with 43 nonusers that there was no
association of PHR use with either self-reported ART adherence
or medical record viral load control [37]. What the evidence in
HIV and in other health conditions suggests is that there is
greater need for randomized studies. This becomes more difficult
as PHRs are increasingly included with EHR packages that
hospitals and health systems adopt; however, there are still
patient groups that have had little or no PHR exposure.
Our findings also point to potential racial disparities in access
to and use of HIV related care. In each of our multivariable
analyses, white patients had greater odds of achieving viral
control than other races (which were overwhelmingly black).
This may be due to uncontrolled variables such as education
level which may vary by race. Other research, including studies
in the VA health care system, suggests various sources for racial
disparities. Richardson et al recently examined racial differences
in HIV care (and in comorbid care for HIV-infected patients)
in VA and reported, “Despite the lack of insurance-related
barriers to care in the equal-access VHA health care system,
racial disparities in the care for veterans with HIV remain
problematic and extend to comorbid conditions” [38]. Whereas
the knowledge about the causes of these disparities is
incomplete, Richardson et al suggest that possible contributors
include patient attitudes and beliefs, provider attitudes and
implicit biases, differences in patient-provider communication,
and social-structural disadvantages by race [39-42].
The persistent finding, in each of our models, of a negative
association between the presence of psychoses and uncontrolled
viral load is noteworthy. This may indicate patients in this group
have difficulty adhering to their HIV medications. Research
into nonadherence (in general, not just for HIV) for persons
with psychoses suggests that there are a number of potential
barriers to adherence to medications. These include lack of
social support, problems with therapeutic alliance, lack of daily
routines, negative attitudes toward medications, and cognitive
deficits [43].
More broadly, among persons with HIV, adoption and use of
PHRs have been associated with a number of sociodemographic
characteristics. A study of veterans with HIV found that PHR
use is associated with younger age, less than excellent or very
good health, white race, more education, lack of substance use
disorder, and higher incomes [4]. Patient PHR use also has some
advantages over face-to-face communication. For health-related
questions that are perceived by patients as sensitive or that may
cause embarrassment or perceived stigma, PHRs provide a sense
of privacy and anonymity [26,44].
PHRs provide patients with greater access to their providers
and health information, and also provide tools that allow patients
to undertake health self-management tasks more efficiently than
through in-person or phone contact with their health care team
[45-47]. Patients report that accessing information in their PHR
can enhance communication with providers, for example through
improved preparation for in-person visits. PHRs and the
information they contain also aid patients by improving
knowledge of their health, serving as reminders for needed
follow up, and creating a sense of accountability for one’s health
that leads to more self-care [48]. Accordingly, PHRs can be
expected to enable patients to increase self-management of
chronic conditions, resulting in better control of those conditions
and better health overall. However, it is unclear whether simply
providing a PHR to patients is sufficient to achieve this, as
indicated by the results of the study by Wagner et al described
previously [30]. With the provision of PHRs, there may be a
need for patient orientation, training, and continued promotion
to increase both adoption and sustained use, and to encourage
specific uses that are likely to have the most health-related
benefits.
Conclusions
Our examination of PHR use adds important information to the
existing body of work. Our data come from a highly stigmatized
and vulnerable population of veterans with HIV, many of whom
have high economic need, are racial or ethnic minorities, have
a mental health or substance use disorder, and may lack social
support (only 11% married). Interestingly, this population has
been shown to use VA’s My HealtheVet PHR more than other
chronic disease groups [15]; however, the cause of this
phenomenon is not completely clear. That the use of a PHR
electronic prescription refill feature was positively associated
with undetectable viral load status in this vulnerable population
is encouraging in that it may indicate an augmentation of access
to medications and providers. The PHR tools of Rx refill and
SM may afford patients a greater sense of freedom to perform
functions—ordering refills and communicating with
providers—unencumbered by the risk of social stigma associated
with face-to-face or phone contacts [26]. Reducing such stigma
may encourage greater patient interactions with providers and
the health care system when issues arise, and improve
self-efficacy in addressing health-related tasks and challenges.
This in turn should help reduce the occurrence of patients
running out of prescription medications and also facilitate swift
resolution of serious side effects a patient may be experiencing
from medications or drug-drug interactions.
Given our observational study design, however, further
examination of the potential benefits of PHRs, and tools such
as electronic prescription refill, are merited, especially if they
can involve randomization. That a considerable proportion of
this population is using PHR tools is encouraging—and yet
about two-thirds do not. This suggests that continued efforts
are needed to reach out to this population and to provide eHealth
tools that are seen as easy to use and beneficial, regardless of
the background or socio-economic and health status of the
potential user.
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